Company intelligence / Profile preview
Britannia Pharmaceuticals
Reading, England, United Kingdombritannia-pharm.co.uk ↗
- Ownership
- Private
- Employees
- ~87
- Development stage
- Commercial
01
Overview
Britannia Pharmaceuticals has over three decades of experience developing and commercializing innovative, patient-centric therapies for Parkinson’s disease and other long-term neurological conditions. The company markets world-leading medications, supports clinical trials, and invests in care initiatives to optimize treatment programs. It operates as the global specialty center for Parkinson’s Disease within the STADA group network.[2][3][4] Recent patents include new therapeutic compositions containing apomorphine as an active ingredient.[6] The company has received recognition such as the Queen’s Award for Enterprise in International Trade.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small molecules (notably apomorphine and dopamine agonists)[6]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
STADA Group network partnerships across more than 30 countries worldwide; no specific external pharma/biotech partners named publicly.[9]
Beyond the preview
Go deeper on Britannia Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Britannia Pharmaceuticals.